Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

Clinical trial NCT05093972 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05093972
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2027-01-22
Primary completion: 2027-06-29
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.